Clinical Trial

Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Post-Market Clinical Follow-up Registry of Patients with CODMAN CERTAS Plus Programmable Valves.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2022-05-25; most recent amendment 2026-02-25.
Status change: Recruiting → Active, Not Recruiting 2026-02-25
Status change: Not Yet Recruiting → Recruiting 2023-01-30
Trial Details
NCT Number NCT05397106
Lead Sponsor Integra LifeSciences Corporation
Conditions Hydrocephalus, Hydrocephalus in Children, NPH (Normal Pressure Hydrocephalus), IIH - Idiopathic Intracranial Hypertension, Brain Tumor, Post-Traumatic Hydrocephalus, Hemorrhagic Stroke
Enrollment 160 participants
Start Date 2023-01-24
Primary Completion 2029-01-24 (estimated)
Study Completion 2029-01-24 (estimated)
Updated on ClinicalTrials.gov 2026-02-27